View Older Stories View More Recent Stories
-
Form SC 13G/A Vaxcyte, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Atea Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Frazier Lifesciences Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G CURIS INC Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Akouos, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Inozyme Pharma, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Olema Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Trillium Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Lyra Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G CONCERT PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Verastem, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A RELMADA THERAPEUTICS, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Travere Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Pandion Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A ChemoCentryx, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G 5:01 Acquisition Corp. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G BCLS Acquisition Corp. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A scPharmaceuticals Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Kinnate Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Silverback Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Orchard Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G GERON CORP Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Dyne Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Adverum Biotechnologies, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Inhibrx, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Helix Acquisition Corp Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A X4 Pharmaceuticals, Inc Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Larimar Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G ARYA Sciences Acquisitio Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G NOVAVAX INC Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A RHYTHM PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A ARDELYX, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Phathom Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G FIVE PRIME THERAPEUTICS, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G BCTG Acquisition Corp. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Crinetics Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Milestone Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A ZOGENIX, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Verona Pharma plc Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Prevail Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31
-
Form SC 13G/A Iterum Therapeutics plc Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Cyteir Therapeutics Secures $80 Million in Series C Financing to Advance Clinical Trials of Lead RAD51 Program
-
Form SC 13G/A TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Keros Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A ARVINAS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Cardiff Oncology, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G Keros Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

